IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-25690-5.html
   My bibliography  Save this article

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

Author

Listed:
  • Denise A. Cobb

    (University of Nebraska Medical Center)

  • Nathan Smith

    (University of Nebraska Medical Center)

  • Suyash Deodhar

    (University of Nebraska Medical Center)

  • Aditya N. Bade

    (University of Nebraska Medical Center)

  • Nagsen Gautam

    (University of Nebraska Medical Center)

  • Bhagya Laxmi Dyavar Shetty

    (University of Nebraska Medical Center)

  • JoEllyn McMillan

    (University of Nebraska Medical Center)

  • Yazen Alnouti

    (University of Nebraska Medical Center)

  • Samuel M. Cohen

    (University of Nebraska Medical Center)

  • Howard E. Gendelman

    (University of Nebraska Medical Center
    University of Nebraska Medical Center)

  • Benson Edagwa

    (University of Nebraska Medical Center)

Abstract

Treatment and prevention of human immunodeficiency virus type one (HIV-1) infection was transformed through widespread use of antiretroviral therapy (ART). However, ART has limitations in requiring life-long daily adherence. Such limitations have led to the creation of long-acting (LA) ART. While nucleoside reverse transcriptase inhibitors (NRTI) remain the ART backbone, to the best of our knowledge, none have been converted into LA agents. To these ends, we transformed tenofovir (TFV) into LA surfactant stabilized aqueous prodrug nanocrystals (referred to as NM1TFV and NM2TFV), enhancing intracellular drug uptake and retention. A single intramuscular injection of NM1TFV, NM2TFV, or a nanoformulated tenofovir alafenamide (NTAF) at 75 mg/kg TFV equivalents to Sprague Dawley rats sustains active TFV-diphosphate (TFV-DP) levels ≥ four times the 90% effective dose for two months. NM1TFV, NM2TFV and NTAF elicit TFV-DP levels of 11,276, 1,651, and 397 fmol/g in rectal tissue, respectively. These results are a significant step towards a LA TFV ProTide.

Suggested Citation

  • Denise A. Cobb & Nathan Smith & Suyash Deodhar & Aditya N. Bade & Nagsen Gautam & Bhagya Laxmi Dyavar Shetty & JoEllyn McMillan & Yazen Alnouti & Samuel M. Cohen & Howard E. Gendelman & Benson Edagwa, 2021. "Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25690-5
    DOI: 10.1038/s41467-021-25690-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-25690-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-25690-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Suyash Deodhar & Brady Sillman & Aditya N. Bade & Sean N. Avedissian & Anthony T. Podany & JoEllyn M. McMillan & Nagsen Gautam & Brandon Hanson & Bhagya L. Dyavar Shetty & Adam Szlachetka & Morgan Joh, 2022. "Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25690-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.